Pharma Presentation

14
. By--- SRITAMA CHOUDHURY PURVI CHORARIA HONEY SINGH SNEHA BHOWMICK

description

Pharmaceutical presentation oof marketing basics.

Transcript of Pharma Presentation

.

.

By--- SRITAMA CHOUDHURYPURVI CHORARIAHONEY SINGHSNEHA BHOWMICK

IntroductionThePharmaceutical industryin Indiais the world's third-largest in terms of volume according to Department of Pharmaceuticals of the IndianMinistry of Chemicals and Fertilizers

According toIndia Brand Equity Foundation, the Indian pharmaceutical market is likely to grow at acompound annual growth rate(CAGR) of 15-17 per cent in between 2013-16.India is now among the top five pharmaceutical emerging markets of the world

Exports of pharmaceuticals products from India has registered an annual growth rate of 25% as per Ministry of Commerce

In 2014, there were 250 large units and about 8,000 small scale pharmaceutical manufacturing plants in India, employing over 345 thousand workersHISTORY In 1930, in Calcutta the first pharmaceutical company called Bengal Chemicals and Pharmaceutical Works, which still is today as one of 5 government-owned drug manufacturers was started.

On April 27, 1936, East India Pharmaceutical Works Limited (EIPWL)- one of the oldest pharmaceutical companies of India was born.

The Indian pharmaceutical sector is highly fragmented, with more than 24,000 registered companies, with the top 250 companies controlling 70-80% of the market.

Thegovernmentstarted to encourage the growth of drug manufacturing by Indian companies in the early 1960s

Top 5 Pharmaceutical companies in India

Dr Reddys Labs With total net sales of Rs 9728.00 crores, Dr Reddys Labs is the largest pharmaceutical company in India.

CiplaWith total net sales of Rs 9,380.29 crores, Cipla is the second largest pharmaceutical company in India.

Lupin With total net sales of Rs 8,939.38 crores Lupin is the third largest pharmaceutical company in India.

Aurobindo Pharma Aurobindo Pharma is the fourth largest pharma company in India with the total net sales of Rs 7,110.11 crores.

Ranbaxy Labs Ranbaxy is on 5th position with the total net sales of Rs 6,864.64 crores

http://www.moneycontrol.com/stocks/marketinfo/netsales/bse/pharmaceuticals.htmlTop 5 Pharmaceutical companies in w.bAlextra Pharmaceuticals

Medplus

C. I. Laboratories

Lucky Pharma

Highland Drugs

Source: http://west-bengal-state.infoisinfo.co.in/search/pharma_company

East India Pharmaceutical Works Ltd

Source- http://west-bengal-state.infoisinfo.co.in/search/pharma_companyGrowth factor Rise in prevalence of disease

Socio Economic Growth and Urbanization

Increasing acceptability of modern medicine Greater Medical Reach in the Rural Areas

More affordably and accessible drugs and medical care

Improvements in healthcare infrastructure

Increase in health insurance coverage

Government regulations targeting growth and competitive market

Contract R&D

Medical Tourism Growth Factors for Indian MarketRecent newsLupin launches generic version of Diovan tablets in US market

Glenmark gets shareholders' nod to raise up to $300 mn

Cipla wins AIDS drug tender worth 2 billion rand from South Africa's health department

Dr Reddy's Labs acquires Habitrol brand

MP to introduce online licensing of drug firms

Romania to tie up with domestic pharma companies

Delhi HC bars Cipla from selling copy of Novartis respiratory drug

Govt plans to inject life into sick PSU drug makers using Make in India' pitch

Dr Reddys LabsDr. Reddy's Laboratories Ltd, is a pharmaceutical company headquartered inHyderabad,Telangana, India. The company was founded byAnji Reddy,in 1984 who had previously worked in the mentor institute,Indian Drugs and Pharmaceuticals Limited, ofHyderabad, India

The company has over 200 innovative medications, 60active pharmaceutical ingredients(APIs) for drug manufacture, diagnostic kits,critical care, andbiosimilarproducts.

By 2007, Dr. Reddy's had six FDA plants producing active pharmaceutical ingredients in India and seven FDA-inspected andISO 9001(quality) andISO 14001(environmental management) certified plants making patient-ready medications five of them in India and two in the UK.

In 2010, the family-controlled Dr Reddy's denied[3]that it was in talks to sell its generics business in India to US pharmaceutical giantPfizer

Dr Reddy's Laboratorieshas acquired Habitrol brand, a nicotine replacement therapy from Novartis Consumer Health Inc

CiplaIt was founded by Dr.Khwaja Abdul Hamiedas 'The Chemical, Industrial & Pharmaceutical Laboratories' in 1935 in Mumbai.

Net Profit--- Rs 299 cr

No. Share---802.92

Export-------49.0%(12-March14)

Highlights-Continuous innovation in R &D, over 20 world firsts.Over 2,000 products, 65 therapeutic categories, over 50 dosage forms.Presence in over 170 countries

The company offers active pharmaceutical ingredients (APIs); and formulations in therapeutic areas, such as allergy, analgesic, anti malarial, anti-infective, cardiology, dermatology diabetology, gastroenterology, HIV-AIDS, hormones and steroids, respiratory, urology, and womens health in various dosage forms.

LupinLupin Limitedis a transnationalpharmaceuticalcompany based inMumbai.It is the 2nd largestIndian pharma company bymarket capitalization of Rs639,231.The 14th largest genericpharmaceutical companyglobally.There has been an increase in export in yoy from Rs 43,157 to Rs 57,177.Lupin was founded in 1968 byDr. Desh Bandhu Gupta.ProductsPharmaceuticals, Branded and generic drugs,Biotechnology, AdvancedDrug Delivery Systems,New Chemical Entity Research,Vaccines,Over-the-Counter drugs

Marketing strategies for pharmaceutical companiesPharmaceutical representatives

Free samples

Continuing medical education

Journal articles

Drug coupons

Distribution channel

Sales Force Structure